MARKET WIRE NEWS

Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-12 18:42:42 ET

Journey Medical Corporation (DERM)

Q2 2025 Earnings Conference Call

August 12, 2025 04:30 PM ET

Company Participants

Claude Maraoui - Founder, President, CEO & Director

Jaclyn Jaffe - Senior Director of Corporate Operations

Joseph M. Benesch - CFO & Corporate Controller

Ramsey Alloush - COO, General Counsel & Company Secretary

Conference Call Participants

Mayank Mamtani - B. Riley Securities, Inc., Research Division

Scott Robert Henry - Alliance Global Partners, Research Division

Thomas Flaten - Lake Street Capital Markets, LLC, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's Second Quarter 2025 Financial Results and Corporate Update Conference Call....

Read the full article on Seeking Alpha

For further details see:

Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript
Journey Medical Corporation

NASDAQ: DERM

DERM Trading

-2.47% G/L:

$8.08 Last:

31,404 Volume:

$8.03 Open:

mwn-app Ad 300

DERM Latest News

DERM Stock Data

$266,218,987
14,090,816
2.7%
16
N/A
Pharmaceuticals
Healthcare
US
Scottsdale

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App